NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Key characteristics
| NTR | BMY | |
|---|---|---|
| YTD Return | -5.75% | -10.55% |
| 1Y Return | -20.97% | -30.81% |
| 3Y Return (Ann) | 1.05% | -8.97% |
| 5Y Return (Ann) | 3.02% | 2.94% |
| Sharpe Ratio | -0.68 | -1.46 |
| Daily Std Dev | 30.92% | 21.41% |
| Max Drawdown | -55.30% | -70.62% |
| Current Drawdown | -51.16% | -41.41% |
Fundamentals
| NTR | BMY | |
|---|---|---|
| Market Cap | $26.01B | $90.90B |
| EPS | $2.53 | -$3.10 |
| PE Ratio | 20.77 | 12.68 |
| Revenue (TTM) | $28.08B | $45.53B |
| Gross Profit (TTM) | $15.42B | $36.38B |
| EBITDA (TTM) | $5.33B | $18.20B |
Correlation
The correlation between NTR and BMY is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NTR vs. BMY - Performance Comparison
In the year-to-date period, NTR achieves a -5.75% return, which is significantly higher than BMY's -10.55% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 4.05%, less than BMY's 5.22% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 4.05% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 5.22% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -55.30%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Volatility
NTR vs. BMY - Volatility Comparison
The current volatility for Nutrien Ltd. (NTR) is 6.30%, while Bristol-Myers Squibb Company (BMY) has a volatility of 10.13%. This indicates that NTR experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities